{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:24:20Z","timestamp":1793741060118,"version":"4.6.1"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001634","name":"Gateway for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.redox.2021.101864","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T02:41:51Z","timestamp":1610937711000},"page":"101864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy"],"prefix":"10.1016","volume":"42","author":[{"given":"M.S.","family":"Petronek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Stolwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.D.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zakharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.R.","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.G.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metabol."},{"issue":"9","key":"10.1016\/j.redox.2021.101864_bib2","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1172\/JCI120844","article-title":"Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy","volume":"128","author":"Zhu","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semradonc.2018.10.010","article-title":"Manipulations of redox metabolism for enhancing radiation therapy responses: a historical perspective and novel hypothesis","volume":"29","author":"Spitz","year":"2019","journal-title":"Semin. Radiat. Oncol."},{"issue":"8","key":"10.1016\/j.redox.2021.101864_bib4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/cancers11081077","article-title":"Linking cancer metabolic dysfunction and genetic instability through the lens of iron metabolism","volume":"11","author":"Petronek","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib5","first-page":"1141","article-title":"Role of superoxide dismutase in cancer: a review","volume":"39","author":"Oberley","year":"1979","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20081258","article-title":"Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation","volume":"418","author":"Aykin-Burns","year":"2009","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic. Res."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib8","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.3390\/nu7053536","article-title":"Redox-active selenium compounds--from toxicity and cell death to cancer treatment","volume":"7","author":"Misra","year":"2015","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/187152011795677544","article-title":"Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide","volume":"11","author":"Buettner","year":"2011","journal-title":"Anti Canc. Agents Med. Chem."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0306-9877(80)90123-1","article-title":"Cell differentiation, aging and cancer: the possible roles of superoxide and superoxide dismutases","volume":"6","author":"Oberley","year":"1980","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0306-9877(81)90018-9","article-title":"Cell division in normal and transformed cells: the possible role of superoxide and hydrogen peroxide","volume":"7","author":"Oberley","year":"1981","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism OF tumors IN the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib13","doi-asserted-by":"crossref","first-page":"E725","DOI":"10.1073\/pnas.1508779113","article-title":"Transketolase counteracts oxidative stress to drive cancer development","volume":"113","author":"Xu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0360-3016(92)90500-H","article-title":"Sensitivity to chemical oxidants and radiation in CHO cell lines deficient in oxidative pentose cycle activity","volume":"22","author":"Tuttle","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"24","key":"10.1016\/j.redox.2021.101864_bib15","doi-asserted-by":"crossref","first-page":"39896","DOI":"10.18632\/oncotarget.16379","article-title":"Melatonin for the prevention and treatment of cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib16","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3390\/ijms14022410","article-title":"Melatonin anticancer effects: review","volume":"14","author":"Di Bella","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2021.101864_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biochi.2015.04.014","article-title":"Redox regulation and pro-oxidant reactions in the physiology of circadian systems","volume":"124","author":"M\u00e9ndez","year":"2016","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/bph.12457","article-title":"Melatonin MT\u2081 and MT\u2082 receptors display different molecular pharmacologies only in the G-protein coupled state","volume":"171","author":"Legros","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2011.00931.x","article-title":"Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations","volume":"52","author":"Venegas","year":"2012","journal-title":"J. Pineal Res."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/molpharm.120.000105","article-title":"Molecular pharmacology of NRH:quinone oxidoreductase 2: a detoxifying enzyme acting as an undercover toxifying enzyme","volume":"98","author":"Janda","year":"2020","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1600-079X.2010.00847.x","article-title":"Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro","volume":"50","author":"Bonnefont-Rousselot","year":"2011","journal-title":"J. Pineal Res."},{"issue":"39","key":"10.1016\/j.redox.2021.101864_bib22","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1039\/C4OB01396D","article-title":"Theoretical insight into the antioxidant properties of melatonin and derivatives","volume":"12","author":"Johns","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"1035","key":"10.1016\/j.redox.2021.101864_bib23","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br. J. Radiol."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1006\/bbrc.1998.9826","article-title":"A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation","volume":"253","author":"Tan","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jpi.12010","article-title":"On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK","volume":"54","author":"Galano","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.redox.2021.101864_bib26","first-page":"21","article-title":"Cyclic-3-hydroxymelatonin (C3HOM), A potent antioxidant, scavenges free radicals and suppresses oxidative reactions","author":"Tan","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.redox.2021.101864_bib27","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1021\/bi702016q","article-title":"Melatonin is a potent inhibitor for myeloperoxidase","volume":"47","author":"Galijasevic","year":"2008","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.redox.2021.101864_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/153537020222600718","article-title":"Melatonin attenuates estradiol-induced oxidative damage to DNA: relevance for cancer prevention","volume":"226","author":"Karbownik","year":"2001","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/jcb.10689","article-title":"Melatonin reduces fenton reaction-induced lipid peroxidation in porcine thyroid tissue","volume":"90","author":"Karbownik","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.redox.2021.101864_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/cells8080903","article-title":"Antioxidant and pro-oxidant activities of melatonin in the presence of copper and polyphenols in vitro and in vivo","volume":"8","author":"Wang","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib31","first-page":"207","article-title":"Breast cancer and circadian disruption from electric lighting in the modern world","volume":"64","author":"Stevens","year":"2014","journal-title":"CA A Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib32","article-title":"Light exposure at night, sleep duration, melatonin, and breast cancer: a dose\u2013response analysis of observational studies","volume":"23","author":"Yang","year":"2014","journal-title":"Eur. J. Canc. Prevent."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.aje.a114569","article-title":"Electric power use and breast cancer: a hypothesis","volume":"125","author":"Stevens","year":"1987","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0024-3205(99)00262-3","article-title":"Melatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitro","volume":"65","author":"Mediavilla","year":"1999","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.bjc.6601626","article-title":"Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?","volume":"90","author":"Schernhammer","year":"2004","journal-title":"Br. J. Canc."},{"issue":"5A","key":"10.1016\/j.redox.2021.101864_bib36","first-page":"3615","article-title":"Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer","volume":"18","author":"Me\u0142en-Mucha","year":"1998","journal-title":"Anticanc. Res."},{"key":"10.1016\/j.redox.2021.101864_bib37","first-page":"49","article-title":"Radical-scavenging activity of melatonin, either alone or in combination with vitamin E, ascorbate or 2-mercaptoethanol as Co-antioxidants, using the induction period method. In vivo (athens, Greece)","volume":"25","author":"Kadoma","year":"2010"},{"issue":"11\u201312","key":"10.1016\/j.redox.2021.101864_bib38","first-page":"1333","article-title":"Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells","volume":"45","author":"S\u00e1nchez-S\u00e1nchez","year":"2011"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pros.20155","article-title":"Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism","volume":"63","author":"Sainz","year":"2005","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20081258","article-title":"Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation","volume":"418","author":"Aykin-Burns","year":"2009","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jpi.12162","article-title":"Melatonin: a well-documented antioxidant with conditional pro-oxidant actions","volume":"57","author":"Zhang","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.redox.2021.101864_bib42","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.21873\/anticanres.12681","article-title":"Melatonin promotes apoptosis of colorectal cancer cells via superoxide-mediated ER stress by inhibiting cellular prion protein expression","volume":"38","author":"Chul Won","year":"2018","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(01)02680-1","article-title":"Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells","volume":"502","author":"W\u00f6lfler","year":"2001","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.taap.2009.05.012","article-title":"Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes","volume":"239","author":"Radogna","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0024-3205(00)00955-3","article-title":"Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2","volume":"68","author":"Osseni","year":"2000","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1742-7843.2010.00619.x","article-title":"Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apoptotic effects","volume":"108","author":"Bejarano","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.redox.2021.101864_bib47","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/cancers11071001","article-title":"Prognostic impact of melatonin receptors MT1 and MT2 in non-small cell lung cancer (NSCLC)","volume":"11","author":"Jablonska","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib48","first-page":"157","article-title":"Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers","volume":"19","author":"Kast","year":"2015","journal-title":"Contemp. Oncol."},{"key":"10.1016\/j.redox.2021.101864_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/NDT.S4234","article-title":"New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists","volume":"5","author":"Hardeland","year":"2009","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0091270006298602","article-title":"Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2","volume":"47","author":"Greenblatt","year":"2007","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0091270005283461","article-title":"Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia","volume":"46","author":"Karim","year":"2006","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-079X.2008.00647.x","article-title":"Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production","volume":"46","author":"L\u00f3pez","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.redox.2021.101864_bib53","first-page":"338","article-title":"Alteration of serotonin 2C receptor expression in the aorta and the pulmonary artery in rats exposed to hypoxia","volume":"51","author":"Zhang","year":"2009","journal-title":"Chin. J. Physiol."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-079X.2010.00815.x","article-title":"The role of mitochondrial complex III in melatonin-induced ROS production in cultured mesangial cells","volume":"50","author":"Zhang","year":"2011","journal-title":"J. Pineal Res."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib55","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.3390\/ijms140611259","article-title":"New evidence for cross talk between melatonin and mitochondria mediated by a circadian-compatible interaction with nitric oxide","volume":"14","author":"Sarti","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/iub.603","article-title":"Nanomolar melatonin enhances nNOS expression and controls HaCaT-cells bioenergetics","volume":"64","author":"Arese","year":"2012","journal-title":"IUBMB Life"},{"issue":"15","key":"10.1016\/j.redox.2021.101864_bib57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.lfs.2008.08.004","article-title":"Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats","volume":"83","author":"Othman","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2021.101864_bib58","first-page":"12","article-title":"Mechanisms for radioprotection by melatonin; can it be used as a radiation countermeasure?","author":"Amini","year":"2018","journal-title":"Curr. Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0027-5107(97)00211-X","article-title":"Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes","volume":"397","author":"Vijayalaxmi","year":"1998","journal-title":"Mutat. Res."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib60","first-page":"46","article-title":"Micronuclei assessment of the radioprotective effects of melatonin and vitamin C in human lymphocytes","volume":"18","author":"Rostami","year":"2016","journal-title":"Cell J"},{"key":"10.1016\/j.redox.2021.101864_bib61","first-page":"4087298","article-title":"Melatonin Alleviates Radiation-Induced Lung Injury via Regulation of miR-30e\/NLRP3 Axis","author":"Wu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib62","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/157015910792246236","article-title":"Neurotoxins: free radical mechanisms and melatonin protection","volume":"8","author":"Reiter","year":"2010","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib63","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(95)00218-F","article-title":"Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals","volume":"677","author":"Hirata","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2021.101864_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.1999.tb07986.x","article-title":"Neuroprotective role of melatonin in methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity","volume":"890","author":"Ali","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-079X.2010.00761.x","article-title":"Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines","volume":"48","author":"Tocharus","year":"2010","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib66","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<150::AID-SYN4>3.0.CO;2-B","article-title":"Melatonin attenuates methamphetamine-induced toxic effects on dopamine and serotonin terminals in mouse brain","volume":"30","author":"Hirata","year":"1998","journal-title":"Synapse (New York, NY)"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.1998.tb00359.x","article-title":"In vivo protection by melatonin against \u03b4-aminolevulinic acid-induced oxidative damage and its antioxidant effect on the activity of haem enzymes","volume":"24","author":"Princ","year":"1998","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0891-5849(95)02035-7","article-title":"The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias","volume":"20","author":"Demasi","year":"1996","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib69","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats","volume":"44","author":"Lin","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.redox.2021.101864_bib70","first-page":"857","article-title":"Complete objective response to biological therapy of plurifocal breast carcinoma","volume":"29","author":"Di Bella","year":"2009","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.redox.2021.101864_bib71","first-page":"249","article-title":"The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 23 tumours of the head and neck","volume":"33","author":"Di Bella","year":"2012","journal-title":"Neuroendocrinol. Lett."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib72","first-page":"401","article-title":"Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast","volume":"38","author":"Di Bella","year":"2017","journal-title":"Neuroendocrinol. Lett."},{"issue":"Suppl 1","key":"10.1016\/j.redox.2021.101864_bib73","first-page":"1","article-title":"The Di Bella method (DBM)","volume":"31","author":"Di Bella","year":"2010","journal-title":"Neuroendocrinol. Lett."},{"issue":"8","key":"10.1016\/j.redox.2021.101864_bib74","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","article-title":"Clinical pharmacokinetics of melatonin: a systematic review","volume":"71","author":"Harps\u00f8e","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.redox.2021.101864_bib75","first-page":"66","article-title":"Pharmacokinetics of alternative administration routes of melatonin: a systematic review","author":"Zetner","year":"2015","journal-title":"Drug Res."},{"issue":"20","key":"10.1016\/j.redox.2021.101864_bib76","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0024-3205(99)00479-8","article-title":"Melatonin activates Th1 lymphocytes by increasing IL-12 production","volume":"65","author":"Garc\u00eda-Mauri\u00f1o","year":"1999","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.redox.2021.101864_bib77","first-page":"660","article-title":"Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report","volume":"34","author":"Di Bella","year":"2013","journal-title":"Neuroendocrinol. Lett."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","article-title":"Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis","volume":"39","author":"Mills","year":"2005","journal-title":"J. Pineal Res."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib79","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00280-012-1828-8","article-title":"The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials","volume":"69","author":"Wang","year":"2012","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib80","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-079X.2003.00032.x","article-title":"Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial","volume":"35","author":"Lissoni","year":"2003","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib81","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/bjc.1995.164","article-title":"Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone","volume":"71","author":"Lissoni","year":"1995","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.redox.2021.101864_bib82","first-page":"1951","volume":"23","author":"Cerea","year":"2003","journal-title":"Anticanc. Res."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000227465","article-title":"A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates","volume":"52","author":"Barni","year":"1995","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib84","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10549-014-2962-2","article-title":"Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial","volume":"145","author":"Hansen","year":"2014","journal-title":"Breast Canc. Res. Treat."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5664\/jcsm.5490","article-title":"Effect of melatonin on sleep in the perioperative period after breast cancer surgery: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Madsen","year":"2016","journal-title":"Journal Clincal Sleep Medicine"},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib86","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10549-014-2944-4","article-title":"A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes","volume":"145","author":"Chen","year":"2014","journal-title":"Breast Canc. Res. Treat."},{"issue":"20","key":"10.1016\/j.redox.2021.101864_bib87","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1002\/cncr.29563","article-title":"Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: a double-blind placebo-controlled crossover trial","volume":"121","author":"Lund Rasmussen","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.redox.2021.101864_bib88","first-page":"75","article-title":"Vitamin E contents of foods","author":"McLaughlin","year":"1979","journal-title":"J. Am. Diet Assoc."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib89","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3945\/an.117.016329","article-title":"Natural forms of vitamin E as effective agents for cancer prevention and therapy","volume":"8","author":"Jiang","year":"2017","journal-title":"Advances in Nutrition"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semradonc.2018.10.008","article-title":"Utilization of vitamin E analogs to protect normal tissues while enhancing antitumor effects","volume":"29","author":"Aykin-Burns","year":"2019","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.redox.2021.101864_bib91","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2014.03.035","article-title":"Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy","volume":"72","author":"Jiang","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.redox.2021.101864_bib92","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib93","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1021\/ar200024c","article-title":"Free radical oxidation of polyunsaturated lipids: new mechanistic insights and the development of peroxyl radical clocks","volume":"44","author":"Pratt","year":"2011","journal-title":"Accounts Chem. Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib94","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/abbi.1993.1074","article-title":"The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate","volume":"300","author":"Buettner","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"issue":"4359","key":"10.1016\/j.redox.2021.101864_bib95","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.210504","article-title":"The biology of oxygen radicals","volume":"201","author":"Fridovich","year":"1978","journal-title":"Science (New York, NY)"},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib96","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/oxfordjournals.jbchem.a134369","article-title":"Steady-state kinetics of the catalase reaction in the presence of cyanide","volume":"94","author":"Ogura","year":"1983","journal-title":"J. Biochem."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib97","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.freeradbiomed.2007.11.010","article-title":"Tocopherols and tocotrienols in membranes: a critical review","volume":"44","author":"Atkinson","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"24","key":"10.1016\/j.redox.2021.101864_bib98","doi-asserted-by":"crossref","first-page":"10102","DOI":"10.1021\/ja301680m","article-title":"How lipid unsaturation, peroxyl radical partitioning, and chromanol lipophilic tail affect the antioxidant activity of \u03b1-tocopherol: direct visualization via high-throughput fluorescence studies conducted with fluorogenic \u03b1-tocopherol analogues","volume":"134","author":"Krumova","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2021.101864_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101518","article-title":"Simultaneous detection of the enzyme activities of GPx1 and GPx4 guide optimization of selenium in cell biological experiments","volume":"32","author":"Stolwijk","year":"2020","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/tx00034a003","article-title":"Polyunsaturated fatty acid alkoxyl radicals exist as carbon-centered epoxyallylic radicals: a key step in hydroperoxide-amplified lipid peroxidation","volume":"6","author":"Wilcox","year":"1993","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0748-5514(85)90011-X","article-title":"Mechanisms of lipid peroxidation","volume":"1","author":"Girotti","year":"1985","journal-title":"J. Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib102","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0891-5849(00)00407-X","article-title":"EPR detection of lipid-derived free radicals from PUFA, LDL, and cell oxidations","volume":"29","author":"Qian","year":"2000","journal-title":"Free Radic. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.redox.2021.101864_bib103","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/15216540252774748","article-title":"Peroxiredoxin, a novel family of peroxidases","volume":"52","author":"Rhee","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.redox.2021.101864_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/0471140856.tx0709s49","article-title":"Overview of peroxiredoxins in oxidant defense and redox regulation","author":"Poole","year":"2011","journal-title":"Curr. Protoc. Toxicol."},{"key":"10.1016\/j.redox.2021.101864_bib105","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/10715760701625075","article-title":"The rate of cellular hydrogen peroxide removal shows dependency on GSH: mathematical insight into in vivo H2O2 and GPx concentrations","volume":"41","author":"Ng","year":"2007","journal-title":"Free Radic. Res."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib106","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0748-5514(85)90130-8","article-title":"Phospholiphase A2 dependent release of fatty acids from peroxidized membranes","volume":"1","author":"Sevanian","year":"1985","journal-title":"J. Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101864_bib107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.abb.2016.12.003","article-title":"Peroxiredoxin 6 in the repair of peroxidized cell membranes and cell signaling","volume":"617","author":"Fisher","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.redox.2021.101864_bib108","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.freeradbiomed.2010.07.002","article-title":"Comparison of glutathione peroxidase 1 and peroxiredoxin 6 in protection against oxidative stress in the mouse lung","volume":"49","author":"Liu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib109","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/bi0520737","article-title":"Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase \u03c0 with activity changes in both enzymes","volume":"45","author":"Ralat","year":"2006","journal-title":"Biochemistry"},{"issue":"15","key":"10.1016\/j.redox.2021.101864_bib110","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199404143301501","article-title":"The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers","volume":"330","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2021.101864_bib111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<37::AID-CNCR7>3.0.CO;2-F","article-title":"The effects of supplementation with \u03b1\u2010tocopherol and \u03b2\u2010carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial","volume":"86","author":"Rautalahti","year":"1999","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.redox.2021.101864_bib112","first-page":"933","article-title":"Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland)","volume":"11","author":"Virtamo","year":"2000","journal-title":"Canc. Causes Contr."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib113","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.294.1.56","article-title":"Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial","volume":"294","author":"Lee","year":"2005","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT)","volume":"301","author":"Lippman","year":"2009","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.redox.2021.101864_bib115","series-title":"Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression [Internet]","first-page":"1","article-title":"Diet and lifestyle in prostate cancer","author":"Wilson","year":"2019"},{"issue":"1\u20102","key":"10.1016\/j.redox.2021.101864_bib116","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/biof.5520070115","article-title":"Vitamins E plus C and interacting conutrients required for optimal health","volume":"7","author":"Fred Gey","year":"1998","journal-title":"Biofactors"},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib117","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/carcin\/bgp205","article-title":"Cancer-preventive activities of tocopherols and tocotrienols","volume":"31","author":"Ju","year":"2010","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib118","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/carcin\/bgr261","article-title":"Tocotrienol as a potential anticancer agent","volume":"33","author":"Ling","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib119","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12263-011-0220-3","article-title":"Tocotrienols fight cancer by targeting multiple cell signaling pathways","volume":"7","author":"Kannappan","year":"2012","journal-title":"Genes Nutr."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/153537020523000402","article-title":"\u03b3-Tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing akt and nuclear factor \u03baB activity","volume":"230","author":"Shah","year":"2005","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib121","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000190792","article-title":"Vitamin E delta-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration","volume":"83","author":"Husain","year":"2009","journal-title":"Pharmacology"},{"issue":"8","key":"10.1016\/j.redox.2021.101864_bib122","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jnutbio.2008.06.004","article-title":"Specific accumulation of \u03b3- and \u03b4-tocotrienols in tumor and their antitumor effect in vivo","volume":"20","author":"Hiura","year":"2009","journal-title":"J. Nutr. Biochem."},{"issue":"11","key":"10.1016\/j.redox.2021.101864_bib123","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s10495-009-0406-y","article-title":"Endoplasmic reticulum stress mediates \u03b3-tocotrienol-induced apoptosis in mammary tumor cells","volume":"14","author":"Wali","year":"2009","journal-title":"Apoptosis"},{"issue":"8","key":"10.1016\/j.redox.2021.101864_bib124","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/153537020422900806","article-title":"Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells","volume":"229","author":"Shah","year":"2004","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ijc.26054","article-title":"Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide","volume":"130","author":"Jiang","year":"2012","journal-title":"Int. J. Canc."},{"issue":"51","key":"10.1016\/j.redox.2021.101864_bib126","doi-asserted-by":"crossref","first-page":"17825","DOI":"10.1073\/pnas.0408340102","article-title":"\u03b3-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis","volume":"101","author":"Jiang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.redox.2021.101864_bib127","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/sj.bjc.6604763","article-title":"\u03b3-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways","volume":"99","author":"Yap","year":"2008","journal-title":"Br. J. Canc."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2009.10.012","article-title":"Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells","volume":"291","author":"Yap","year":"2010","journal-title":"Canc. Lett."},{"issue":"11","key":"10.1016\/j.redox.2021.101864_bib129","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-011-0566-7","article-title":"Inhibitors of succinate: quinone reductase\/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death","volume":"28","author":"Ralph","year":"2011","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.redox.2021.101864_bib130","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1394-7","article-title":"Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner","volume":"15","author":"Yan","year":"2015","journal-title":"BMC Canc."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2407-6-13","article-title":"Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines","volume":"6","author":"Campbell","year":"2006","journal-title":"BMC Canc."},{"key":"10.1016\/j.redox.2021.101864_bib132","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jplph.2005.04.014","article-title":"Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of \u03b3-tocotrienol in neoplastic mammary epithelial cells","volume":"162","author":"Sylvester","year":"2005","journal-title":"J. Plant Physiol."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib133","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10549-010-0786-2","article-title":"Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling","volume":"124","author":"Park","year":"2010","journal-title":"Breast Canc. Res. Treat."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib134","first-page":"138","article-title":"Dysregulation of sphingolipid metabolism in cancer","volume":"11","author":"Ryland","year":"2011"},{"issue":"12","key":"10.1016\/j.redox.2021.101864_bib135","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mnfr.201200350","article-title":"Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells","volume":"56","author":"Gopalan","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.redox.2021.101864_bib136","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.freeradbiomed.2016.03.018","article-title":"Vitamin E metabolite 13\u2032-carboxychromanols inhibit pro-inflammatory enzymes, induce apoptosis and autophagy in human cancer cells by modulating sphingolipids and suppress colon tumor development in mice","volume":"95","author":"Jang","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101864_bib137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jnutbio.2017.04.003","article-title":"Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment","volume":"46","author":"Jang","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"10","key":"10.1016\/j.redox.2021.101864_bib138","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1096\/fasebj.13.10.1145","article-title":"Vitamin E: function and metabolism","volume":"13","author":"Brigelius-Floh\u00e9","year":"1999","journal-title":"Faseb. J."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib139","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3945\/ajcn.114.100966","article-title":"\u03b1-Tocopherol disappearance rates from plasma depend on lipid concentrations: studies using deuterium-labeled collard greens in younger and older adults","volume":"101","author":"Traber","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4162\/nrp.2007.1.4.247","article-title":"Alpha-tocopherol transfer protein (alpha-TTP): insights from alpha-tocopherol transfer protein knockout mice","volume":"1","author":"Lim","year":"2007","journal-title":"Nutr. Res. Pract."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib141","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaci.2017.04.030","article-title":"A short course of gamma-tocopherol mitigates LPS-induced inflammatory responses in humans ex vivo","volume":"140","author":"Burbank","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib142","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2008.03.002","article-title":"In vivo \u03b3-tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects","volume":"45","author":"Wiser","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib143","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1211\/0022357011775208","article-title":"Pharmacokinetics and bioavailability of \u03b1-, \u03b3- and \u03b4-tocotrienols under different food status","volume":"53","author":"Yap","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"10.1016\/j.redox.2021.101864_bib144","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ebiom.2015.11.025","article-title":"A phase I safety, pharmacokinetic, and pharmacodynamic presurgical trial of vitamin E \u03b4-tocotrienol in patients with pancreatic ductal neoplasia","volume":"2","author":"Springett","year":"2015","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12263-007-0055-0","article-title":"Adverse effects of vitamin E by induction of drug metabolism","volume":"2","author":"Brigelius-Floh\u00e9","year":"2007","journal-title":"Genes Nutr."},{"key":"10.1016\/j.redox.2021.101864_bib146","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.redox.2021.101864_bib147","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and CancerA randomized controlled trial","volume":"293","author":"The","year":"2005","journal-title":"J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib148","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11745-004-1251-1","article-title":"Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice","volume":"39","author":"Nesaretnam","year":"2004","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib149","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2005.06.036","article-title":"Tumor suppressive effects of tocotrienol in vivo and in vitro","volume":"229","author":"Wada","year":"2005","journal-title":"Canc. Lett."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib150","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/bcr2726","article-title":"Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trial","volume":"12","author":"Nesaretnam","year":"2010","journal-title":"Breast Canc. Res."},{"issue":"18","key":"10.1016\/j.redox.2021.101864_bib151","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.lfs.2005.12.005","article-title":"Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant \u03b3-tocotrienol","volume":"78","author":"Kumar","year":"2006","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib152","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1667\/RR1824.1","article-title":"Gamma-tocotrienol protects hematopoietic stem and progenitor cells in mice after total-body irradiation","volume":"173","author":"Kulkarni","year":"2010","journal-title":"Radiat. Res."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib153","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1667\/RR1632.1","article-title":"\u03b3-Tocotrienol ameliorates intestinal radiation injury and reduces vascular oxidative stress after total-body irradiation by an HMG-CoA reductase-dependent mechanism","volume":"171","author":"Berb\u00e9e","year":"2009","journal-title":"Radiat. Res."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib154","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1667\/RR13398.1","article-title":"Delta-tocotrienol protects mice from radiation-induced gastrointestinal injury","volume":"180","author":"Li","year":"2013","journal-title":"Radiat. Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0006-2952(93)90080-G","article-title":"Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells","volume":"45","author":"Lin","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2021.101864_bib156","first-page":"333","article-title":"Active oxygen generation as a possible mechanism of selenium toxicity","volume":"10","author":"Seko","year":"1997","journal-title":"Biomed. Environ. Sci.: BES (Biomed. Environ. Sci.)"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib157","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/ijms20010225","article-title":"Methylseleninic acid induces lipid peroxidation and radiation sensitivity in head and neck cancer cells","volume":"20","author":"Lafin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.redox.2021.101864_bib158","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/0006-2952(94)90528-2","article-title":"Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells","volume":"47","author":"Lu","year":"1994","journal-title":"Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.redox.2021.101864_bib159","first-page":"5803","article-title":"Inhibition of cell attachment by selenite","volume":"52","author":"Yan","year":"1992","journal-title":"Canc. Res."},{"issue":"18","key":"10.1016\/j.redox.2021.101864_bib160","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1016\/0006-2952(88)90688-0","article-title":"Studies of the role of DNA fragmentation in selenium toxicity","volume":"37","author":"Garberg","year":"1988","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036343","article-title":"Sodium selenide toxicity is mediated by O2-dependent DNA breaks","volume":"7","author":"Peyroche","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib162","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1207\/s15327914nc4801_11","article-title":"High dietary intake of sodium selenite induces oxidative DNA damage in rat liver","volume":"48","author":"Wycherly","year":"2004","journal-title":"Nutr. Canc."},{"issue":"1\u20132","key":"10.1016\/j.redox.2021.101864_bib163","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0891-5849(98)00147-6","article-title":"Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis","volume":"26","author":"Stewart","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib164","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/jcmm.12214","article-title":"Selenium induces a multi-targeted cell death process in addition to ROS formation","volume":"18","author":"Wallenberg","year":"2014","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib165","article-title":"Understanding the redox biology of selenium in the search of targeted cancer therapies","volume":"9","author":"Stolwijk","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"10.1016\/j.redox.2021.101864_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123834","article-title":"Current landscape and the potential role of hypoxia-inducible factors and selenium in clear cell renal cell carcinoma treatment","volume":"19","author":"Garje","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7_suppl","key":"10.1016\/j.redox.2021.101864_bib167","article-title":"Preliminary results of phase I clinical trial of high doses of seleno-L-methionine (SLM) in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients","volume":"37","author":"Garje","year":"2019","journal-title":"J. Clin. Orthod."},{"issue":"12","key":"10.1016\/j.redox.2021.101864_bib168","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1158\/1078-0432.CCR-08-0212","article-title":"Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs","volume":"14","author":"Bhattacharya","year":"2008","journal-title":"Clin. Canc. Res.: Off. J. Am. Assoc. Canc. Res."},{"issue":"7","key":"10.1016\/j.redox.2021.101864_bib169","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1158\/1078-0432.CCR-03-0268","article-title":"Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts","volume":"10","author":"Cao","year":"2004","journal-title":"Clin. Canc. Res.: Off. J. Am. Assoc. Canc. Res."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib170","first-page":"155","article-title":"Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor","volume":"8","author":"Bhattacharya","year":"2009","journal-title":"Clin. Colorectal Canc."},{"issue":"9","key":"10.1016\/j.redox.2021.101864_bib171","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/PAI.0000000000000012","article-title":"Constitutive expression of HIF-\u03b1 plays a major role in generation of clear-cell phenotype in human primary and metastatic renal carcinoma","volume":"22","author":"T\u00f3th","year":"2014","journal-title":"Appl. Immunohistochem. Mol. Morphol.: Appl. Immunohistochem. Mol. Morphol. AIMM"},{"key":"10.1016\/j.redox.2021.101864_bib172","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-293","article-title":"Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition","volume":"12","author":"Chintala","year":"2012","journal-title":"BMC Canc."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib173","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00280-009-1238-8","article-title":"Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha","volume":"66","author":"Chintala","year":"2010","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"7627","key":"10.1016\/j.redox.2021.101864_bib174","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature19795","article-title":"On-target efficacy of a HIF-2\u03b1 antagonist in preclinical kidney cancer models","volume":"539","author":"Cho","year":"2016","journal-title":"Nature"},{"issue":"7627","key":"10.1016\/j.redox.2021.101864_bib175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"Supplement 4","key":"10.1016\/j.redox.2021.101864_bib176","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000000918.02","article-title":"PD39-02\u2003RESULTS OF phase 1 clinical trial OF high doses OF seleno-l-methionine (SLM) IN sequential combination with axitinib IN previously treated and relapsed clear cell renal carcinoma (ccrcc) patients","volume":"203","author":"Zakharia*","year":"2020","journal-title":"J. Urol."},{"issue":"1\u20134","key":"10.1016\/j.redox.2021.101864_bib177","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/biof.5520140115","article-title":"Plasma selenium in specific and non-specific forms","volume":"14","author":"Burk","year":"2001","journal-title":"Biofactors"},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib178","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijrobp.2009.08.013","article-title":"Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology","volume":"78","author":"Muecke","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib179","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1534735414541963","article-title":"Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 Years after cessation of randomization","volume":"13","author":"Muecke","year":"2014","journal-title":"Integr. Canc. Ther."},{"key":"10.1016\/j.redox.2021.101864_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101518","article-title":"Simultaneous detection of the enzyme activities of GPx1 and GPx4 guide optimization of selenium in cell biological experiments","volume":"32","author":"Stolwijk","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib181","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/abbi.1999.1435","article-title":"Failure of selenomethionine residues in albumin and immunoglobulin G to protect against peroxynitrite","volume":"371","author":"Hondal","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib182","first-page":"279","article-title":"The chemical nature of vitamin C","volume":"27","author":"Svirbely","year":"1933","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib183","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbcan.2012.06.003","article-title":"Ascorbic acid: chemistry, biology and the treatment of cancer","volume":"1826","author":"Du","year":"2012","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"4585","key":"10.1016\/j.redox.2021.101864_bib184","doi-asserted-by":"crossref","DOI":"10.1038\/180553a0","article-title":"Missing step in man, monkey and Guinea pig required for the biosynthesis of L-ascorbic acid","volume":"180","author":"Burns","year":"1957","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.redox.2021.101864_bib185","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/archinte.164.21.2335","article-title":"The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals","volume":"164","author":"Hercberg","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"9","key":"10.1016\/j.redox.2021.101864_bib186","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/jn\/137.9.2098","article-title":"Antioxidant supplementation increases the risk of skin cancers in women but not in men","volume":"137","author":"Hercberg","year":"2007","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib187","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/djj050","article-title":"Supplemental and dietary vitamin E, \u03b2-carotene, and vitamin C intakes and prostate cancer risk","volume":"98","author":"Kirsh","year":"2006","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib188","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4082\/kjfm.2015.36.6.278","article-title":"Efficacy of vitamin C supplements in prevention of cancer: a meta-analysis of randomized controlled trials","volume":"36","author":"Lee","year":"2015","journal-title":"Kor. J. Fam. Med."},{"issue":"38","key":"10.1016\/j.redox.2021.101864_bib189","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1078-0432.CCR-09-1713","article-title":"Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer","volume":"16","author":"Du","year":"2010","journal-title":"Clin. Canc. Res."},{"issue":"21","key":"10.1016\/j.redox.2021.101864_bib191","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.0702854104","article-title":"Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid <em>in vivo<\/em>","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"32","key":"10.1016\/j.redox.2021.101864_bib192","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1073\/pnas.0804226105","article-title":"Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib193","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","article-title":"O(2)(\u22c5-) and H(2)O(2)-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate","volume":"31","author":"Schoenfeld","year":"2017","journal-title":"Canc. Cell"},{"key":"10.1016\/j.redox.2021.101864_bib194","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.redox.2017.09.012","article-title":"Redox active metals and H2O2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models","volume":"14","author":"Schoenfeld","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2021.101864_bib195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.redox.2016.10.010","article-title":"Tumor cells have decreased ability to metabolize H2O2: implications for pharmacological ascorbate in cancer therapy","volume":"10","author":"Doskey","year":"2016","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib196","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3892\/mco.2017.1129","article-title":"The role of peroxiredoxins in cancer (Review)","volume":"6","author":"Nicolussi","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib197","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(99)00243-8","article-title":"Peroxiredoxin I expression in human thyroid tumors","volume":"145","author":"Yanagawa","year":"1999","journal-title":"Canc. Lett."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib198","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2015.07.002","article-title":"The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development","volume":"366","author":"Mishra","year":"2015","journal-title":"Canc. Lett."},{"issue":"15","key":"10.1016\/j.redox.2021.101864_bib199","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1158\/0008-5472.CAN-12-4226","article-title":"Peroxiredoxin-2 represses melanoma metastasis by increasing E-cadherin\/\u03b2-catenin complexes in adherens junctions","volume":"73","author":"Lee","year":"2013","journal-title":"Canc. Res."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib200","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00268-008-9521-0","article-title":"Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13","volume":"32","author":"Fernandez-Ranvier","year":"2008","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib201","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3892\/ijo.2013.2208","article-title":"PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms","volume":"44","author":"Nicolussi","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0009-2797(74)90019-2","article-title":"The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer","volume":"9","author":"Cameron","year":"1974","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.redox.2021.101864_bib203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0009-2797(75)90007-1","article-title":"The orthomolecular treatment of cancer: III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy","volume":"11","author":"Cameron","year":"1975","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.redox.2021.101864_bib204","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1073\/pnas.73.10.3685","article-title":"Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer","volume":"73","author":"Cameron","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.redox.2021.101864_bib205","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.75.9.4538","article-title":"Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer","volume":"75","author":"Cameron","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.redox.2021.101864_bib206","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJM197909273011303","article-title":"Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial","volume":"301","author":"Creagan","year":"1979","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib207","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198501173120301","article-title":"High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had No prior chemotherapy","volume":"312","author":"Moertel","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.redox.2021.101864_bib208","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1023\/A:1012186203165","article-title":"Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion","volume":"14","author":"Graumlich","year":"1997","journal-title":"Pharmaceut. Res."},{"issue":"8","key":"10.1016\/j.redox.2021.101864_bib209","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.93.8.3704","article-title":"Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance","volume":"93","author":"Levine","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"7","key":"10.1016\/j.redox.2021.101864_bib210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-140-7-200404060-00010","article-title":"Vitamin C pharmacokinetics: implications for oral and intravenous use","volume":"140","author":"Padayatty","year":"2004","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.redox.2021.101864_bib211","first-page":"115","article-title":"Intravenous vitamin C as a chemotherapy agent: a report on clinical cases","volume":"23","author":"Riordan","year":"2004","journal-title":"Puert. Rico Health Sci. J."},{"issue":"4","key":"10.1016\/j.redox.2021.101864_bib212","first-page":"269","article-title":"A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients","volume":"24","author":"Riordan","year":"2005","journal-title":"Puert. Rico Health Sci. J."},{"issue":"11","key":"10.1016\/j.redox.2021.101864_bib213","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/annonc\/mdn377","article-title":"Phase I clinical trial of i.v. ascorbic acid in advanced malignancy","volume":"19","author":"Hoffer","year":"2008","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"issue":"3","key":"10.1016\/j.redox.2021.101864_bib214","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","article-title":"Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial","volume":"71","author":"Welsh","year":"2013","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"222","key":"10.1016\/j.redox.2021.101864_bib215","doi-asserted-by":"crossref","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"22","key":"10.1016\/j.redox.2021.101864_bib216","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/1078-0432.CCR-19-0594","article-title":"First-in-Human phase I clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma","volume":"25","author":"Allen","year":"2019","journal-title":"Clin. Canc. Res."},{"issue":"10","key":"10.1016\/j.redox.2021.101864_bib217","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.redox.2021.101864_bib218","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1158\/0008-5472.CAN-18-1680","article-title":"Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer","volume":"78","author":"Alexander","year":"2018","journal-title":"Canc. Res."},{"issue":"6","key":"10.1016\/j.redox.2021.101864_bib219","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1158\/1078-0432.CCR-06-1812","article-title":"A phase I\/II study of arsenic trioxide\/bortezomib\/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma","volume":"13","author":"Berenson","year":"2007","journal-title":"Clin. Canc. Res.: Off. J. Am. Assoc. Canc. Res."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.870","article-title":"Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study","volume":"27","author":"Chang","year":"2009","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.redox.2021.101864_bib221","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semradonc.2018.10.006","article-title":"Pharmacological ascorbate as a means of sensitizing cancer cells to radio-chemotherapy while protecting normal tissue","volume":"29","author":"Schoenfeld","year":"2019","journal-title":"Semin. Radiat. Oncol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:18:27Z","timestamp":1761977907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231721000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":221,"alternative-id":["S2213231721000124"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2021.101864","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2021.101864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101864"}}